Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-08-059755
Filing Date
2008-10-28
Accepted
2008-10-28 16:40:04
Documents
5
Effectiveness Date
2008-10-28

Document Format Files

Seq Description Document Type Size
1 v129739_s-8.htm S-8 355807
2 GRAPHIC logo.jpg GRAPHIC 20677
3 v129739_ex5-1.htm EX-5.1 16999
4 v129739_ex23-1.htm EX-23.1 5090
5 v129739_ex23-2.htm EX-23.2 8754
  Complete submission text file 0001144204-08-059755.txt   416658
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: S-8 | Act: 33 | File No.: 333-154795 | Film No.: 081145168
SIC: 2834 Pharmaceutical Preparations